COVID-19 Vaccine In Pregnancy and Lactation (COVIPAL)

 

To address the lack of data on vaccine efficacy and safety in pregnant and lactating populations, our team is launching a study of immune response and pregnancy outcomes after COVID-19 Vaccine in Pregnancy and Lactation (COVIPAL).

Pregnancy Cohort

Eligibility:

  1. Currently pregnant and planning to deliver at UCSF Medical Center.
  2. Planning to receive a COVID-19 vaccine.
  3. Willing to be followed for up to 1 year after delivery.

Study overview:

  1. Surveys about your health, response to vaccine, and your experience related to COVID-19 and vaccination for up to 1 year after birth. 
  2. Specimen donation:
    • Your blood samples (at the time of vaccination, during pregnancy, and at the time of delivery)
    • Placenta
    • Cord blood
    • Breastmilk 
    • Infant blood
  3. Review of medical records

     

    I would Like to LEARN MORE

     

    Lactation Cohort

    Eligibility:

    1. Currently or planning to breastfeed.
    2. Willing to come to UCSF for blood draws.
    3. Planning to receive a COVID-19 vaccine.
    4. Willing to be followed for up to 1 year after vaccination.

    Study overview:

    1. Surveys about your health, response to vaccine, and personal experiences related to COVID-19 and vaccination for up to 1 year after vaccination.
    2. Specimen donation:
      • Your blood samples (before and after vaccination)
      • Breastmilk 
      • Infant blood
    3. Review of medical records

     

    I would Like to LEARN MORE

     

    FAQs

    Other questions? Contact us.

     


    Click here to contact the Gaw Lab. 

    Follow us on Twitter @gaw_lab